Le Jian

Dr. Le Jian

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2003 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
LJLe Jian
Le Jian
LXLi Ping Xie
Li Ping Xie
ALAndy Lee
Andy Lee
CBColin W. Binns
Colin W. Binns
To investigate whether green tea consumption has an etiological association with prostate cancer, a case‐control study was conducted in Hangzhou, southeast China during 2001–2002. The cases were 130 incident patients with histologically confirmed adenocarcinoma of the prostate. The controls were 274 hospital inpatients without prostate cancer or any other malignant diseases, and matched to the age of cases. Information on duration, quantity and frequency of usual tea consumption, as well as the number of new batches brewed per day, were collected by face‐to‐face interview using a structured questionnaire. The risk of prostate cancer for tea consumption was assessed using multivariate logistic regression adjusting for age, locality, education, income, body mass index, physical activity, alcohol consumption, tobacco smoking, total fat intake, marital status, age at marriage, number of children, history of vasectomy and family history of prostate cancer. Among the cases, 55.4% were tea drinkers compared to 79.9% for the controls. Almost all the tea consumed was green tea. The prostate cancer risk declined with increasing frequency, duration and quantity of green tea consumption. The adjusted odds ratio (OR), relative to non‐tea drinkers, were 0.28 (95% CI = 0.17–0.47) for tea drinking, 0.12 (95% CI = 0.06–0.26) for drinking tea over 40 years, 0.09 (95% CI = 0.04–0.21) for those consuming more than 1.5 kg of tea leaves yearly, and 0.27 (95% CI = 0.15–0.48) for those drinking more than 3 cups (1 litre) daily. The dose response relationships were also significant, suggesting that green tea is protective against prostate cancer.

1 June 2012 in Science of The Total Environment
Verified
Journal Article
Closed access
LJLe Jian
Le Jian
YZYun Zhao
Yun Zhao
YZYi-Ping Zhu
Yi-Ping Zhu
MZMei-Bian Zhang
Mei-Bian Zhang
DBDean Bertolatti
Dean Bertolatti

1 June 2013 in Food Research International
Verified
Journal Article
Closed access
DWDavid J. Williams
David J. Williams
DEDavid Edwards
David Edwards
IHIngrid Hamernig
Ingrid Hamernig
LJLe Jian
Le Jian
AJAnthony P. James
Anthony P. James
LTLinda C. Tapsell
Linda C. Tapsell

28 October 2004 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
LJLe Jian
Le Jian
CDChuan-Jun Du
Chuan-Jun Du
ALAndy Lee
Andy Lee
Colin BinnsColin Binns
Colin Binns
To determine whether dietary intake of lycopene and other carotenoids has an etiological association with prostate cancer, a case–control study was conducted in Hangzhou, southeast China during 2001–2002. The cases were 130 incident patients with histologically confirmed adenocarcinoma of the prostate. The controls were 274 hospital inpatients without prostate cancer or any other malignant diseases. Information on usual food consumption, including vegetables and fruits, was collected by face-to-face interviews using a structured food frequency questionnaire. The risks of prostate cancer for the intake of carotenoids and selected vegetables and fruits rich in carotenoids were assessed using multivariate logistic regression, adjusting for age, locality, education, income, body mass index, marital status, number of children, family history of prostate cancer, tea drinking, total fat and caloric intake. The prostate cancer risk declined with increasing consumption of lycopene, α-carotene, β-carotene, β-cryptoxanthin, lutein and zeaxanthin. Intake of tomatoes, pumpkin, spinach, watermelon and citrus fruits were also inversely associated with the prostate cancer risk. The adjusted odds ratios for the highest versus the lowest quartiles of intake were 0.18 (95% CI: 0.08–0.41) for lycopene, 0.43 (95% CI: 0.21–0.85) for α-carotene, 0.34 (95% CI: 0.17–0.69) for β-carotene, 0.15 (95% CI: 0.06–0.34) for β-cryptoxanthin and 0.02 (95% CI: 0.01–0.10) for lutein and zeaxanthin. The corresponding dose–response relationships were also significant, suggesting that vegetables and fruits rich in lycopene and other carotenoids may be protective against prostate cancer.

1 September 2007 in European Journal of Paediatric Neurology
Verified
Journal Article
Closed access
LJLe Jian
Le Jian
LNLakshmi Nagarajan
Lakshmi Nagarajan
NKNicholas de Klerk
Nicholas de Klerk
DRDavid Ravine
David Ravine
JCJohn Christodoulou
John Christodoulou
HLHelen Leonard
Helen Leonard

1 October 2006 in The Journal of Pediatrics
Verified
Journal Article
Closed access
LJLe Jian
Le Jian
LNLakshmi Nagarajan
Lakshmi Nagarajan
NKNicholas de Klerk
Nicholas de Klerk
DRDavid Ravine
David Ravine
CBCarol Bower
Carol Bower
HLHelen Leonard
Helen Leonard